英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
ordentlich查看　ordentlich　在百度字典中的解释百度英翻中〔查看〕
ordentlich查看　ordentlich　在Google字典中的解释Google英翻中〔查看〕
ordentlich查看　ordentlich　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Myelodysplastic Syndromes Treatment (PDQ®)–Patient Version
    Myelodysplastic syndromes (MDS) treatment options include supportive care, drug therapy, and chemotherapy with allogeneic stem cell transplant Learn more about newly diagnosed or recurrent MDS and its treatment in this expert-reviewed summary
  • Treating Myelodysplastic Syndromes | MDS Treatment
    Treating Myelodysplastic Syndromes If you’ve been diagnosed with a myelodysplastic syndrome (MDS), your treatment team will discuss your options with you It’s important to weigh the benefits of each treatment option against the possible risks and side effects
  • Myelodysplastic syndromes - Diagnosis and treatment - Mayo Clinic
    For myelodysplastic syndromes, questions to ask your doctor might include: What type of myelodysplastic syndrome do I have? Will I need more tests? What is my prognosis? What is my risk of leukemia? If I need treatment, what are my options and what do you recommend? I have other health conditions How can I best manage them together?
  • Whats New in Myelodysplastic Syndrome (MDS) Research?
    What's New in Myelodysplastic Syndrome (MDS) Research? Research into the causes, diagnosis, and treatment of myelodysplastic syndromes (MDS) is being done at many cancer research centers around the world
  • Myelodysplastic syndromes: Updates on Genomic Landscape . . .
    Summary Several recent targeted drug approvals including luspatercept and imetelstat have greatly expanded the treatment arsenal for lower-risk MDS Standard of care therapy options for high-risk MDS, in particular TP53 -mutated, remain limited beyond HMAs and transplant and are an active area of investigation
  • Myelodysplastic Myeloproliferative Neoplasms Treatment (PDQ®)
    Patients with MDS MPN do not have a Philadelphia chromosome or a BCR:: ABL1 gene fusion An international consortium has proposed uniform response criteria to be used in clinical trials because of the spectrum of presentations ranging from the myelodysplastic to the myeloproliferative [6] References Treatment of Chronic Myelomonocytic Leukemia
  • Tests and treatment for myelodysplastic syndrome | Cancer . . .
    Tests and treatment for myelodysplastic syndromes (MDS) The main tests for MDS are blood and bone marrow tests You may not need any treatment at first Treatment for MDS includes chemotherapy and other supportive treatments to control your symptoms
  • Updates in Treatment Options for TP53-Mutant AML and MDS
    Conclusion In summary, AML and MDS patients who have the TP53 gene mutation are encouraged to find and or meet with their specialist to discuss receiving cellular therapies through clinical trials Some of these cellular therapies include an anti-CD123 antibody or off-the-self CAR treatments, which use donor immune system cells to kill cancer
  • Therapy for lower-risk MDS | Hematology, ASH Education . . .
    Learning Objectives Review the treatment paradigm and agents for lower risk MDS, with attention to differing treatment options for transfusion dependent anemia, isolated thrombocytopenia, and pancytopenia Describe the expected clinical outcomes for patients diagnosed with lower-risk MDS Describe the impact of somatic mutations on diagnosis of lower-risk MDS (ie; SF3B1 mut vs TP53 mut) and
  • Myelodysplastic syndromes: ESMO Clinical Practice Guidelines . . .
    Myelodysplastic syndromes (MDS) are clonal haematopoietic stem cell (HSC) disorders predominating in the elderly, characterised by ineffective haematopoiesis leading to blood cytopaenias and progression to acute myeloid leukaemia (AML) in one-fourth to one-third of cases 1 Their pathophysiology is characterised by a multi-step process involving cytogenetic changes and or gene mutations,2





中文字典-英文字典  2005-2009